SIRT1 and chronic obstructive pulmonary disease: Nucleosides activate SIRT1 and suppress the NF-κB/p65 pathway while also reducing TGF-β1/Smad signaling and increasing Smad7 expression, thereby attenuating airway inflammation and fibrosis in RAW264.7 macrophages and mice with COPD [66].